By Cindy Marx, Practice Manager, Raj Plastic Surgery
The i-Lipo laser from Chromogenex offers a safe and effective means to achieve immediate and measurable inch loss. i-Lipo uses low-level laser technology to stimulate the body’s natural process for releasing its stored fat, shrinking those fat cells helping to re-contour the body.
The human body stores excess calories from your diet in adipose tissue. When needed, those fat cells will break down their stored triglycerides into free fatty acids, glycerol and water, providing the body with energy during times of scarcity. That same metabolic process that is induced hormonally by the brain can also be triggered by low-level laser energy delivered by i-Lipo. Exercise creates a demand in our bodies for extra energy. Exercising after an i-Lipo treatment helps to burn the fat released from an i-Lipo treatment. More effectively assisting those who already are watching their calorie intake but need an extra boost to reduce those areas of fat that seem to be resistant to exercise.
i-Lipo is a revolutionary, non-invasive body shaping technology offering convenient, safe and pain free body contouring in as little as twenty minutes, without surgery and without downtime. This noninvasive approach to fat reduction can be used year-round on all skin types.
Clinical studies have confirmed the efficacy of the i-Lipo diode laser to deliver body shaping results. Two treatments per week for four weeks are recommended. All parts of the body can be treated where fat is stored, including the waistline, thighs, arms, leg and even under the chin. Patients typically report a 10% inch loss reduction following a treatment regimen.
i-Lipo is the first direct skin contact laser designed for fat reduction and body contouring to receive FDA approval for circumferential reduction. With proper diet and exercise over the course of eight i-Lipo sessions dramatic achievements in body reshaping are noticed.
Call Raj Plastic Surgery, 440-808-8030, mention The Women’s Journal to receive a courtesy i-Lipo consultation.